Why is the study being conducted in Peru, Ecuador, the United States, South Africa, Brazil and Thailand?
Peru, Ecuador, the United States, South Africa, Brazil and Thailand were selected for this study because: · MSM in these countries are highly affected by the epidemic. Studies indicate that prevalence of HIV infection in MSM is 10 percent or greater in these countries. · Site Investigators have an outstanding record of conducting HIV research. All sites have demonstrated high levels of compliance with international clinical trial standards. · The governments of these countries have taken strong leadership roles in HIV prevention, and understand the importance of HIV research and how it can benefit their citizens. · It is essential that prevention research takes place where the epidemic is.
